Ayoxxa is a biotech company offering a revolutionary technology platform for protein multiplexing. Getting more relevant results within a short period of time makes Ayoxxa’s technology highly efficient.
Ayoxxa is a biotech company offering a revolutionary technology platform for protein multiplexing. Getting more relevant results within a short period of time makes Ayoxxa’s technology highly efficient.
TIB MolBiol is a biotech company providing custom synthesis of oligonucleotides to a growing number of customers worldwide. Being one of the first suppliers of synthetic DNA in Europe, TIB MolBiol continues to lead in fulfilling the increasing requirements for high quality products and services.
Integrated DNA Technologies (IDT) is a leading provider of custom oligonucleotides.
BMG Labtech is a leading provider of innovative, high-quality, and reliable microplate readers.
Zymo Research proposes genome-wide epigenetic analyses, featuring state-of-the-art sample preparation technologies and workflows, cutting-edge bioinformatics, and competitive prices.
Scienon is a leading biotech company supplying quality instrumentation and services for low volume liquid handling. Scienon’s proprietary technologies include surface modifications, piezo electric dispensing and microarray manufacturing.
ChemoMetec is a biotech company aiming to improve analytical measurement techniques within the fields of particle counting and liquid chemical composition determination. ChemoMetec mainly focus in liquids analysis, especially for use in life sciences research, clinical diagnostics, production and quality control for pharmaceutical industries.
eBioscience is a biotech company providing high quality reagents that empower the process of scientific discovery in cellular immunity and oncology, mainly focusing in flow cytometry and immunodetection.
Next-generation sequencing (NGS) technology is revolutionizing the way we practice not only genetics but medicine as a whole. NGS technology will improve the diagnostics for millions of patients and will finally enable better treatments options. For physicians this represents a huge challenge. Large data sets need to be analyzed and only sophisticated computer-assisted tools will enable health professionals to do so.
Axiogenesis is an international leader in the development and commercialization of in vitro models of healthy and diseased cell types and tissue. Axiogenesis uses stem cells to revolutionize the fields of drug discovery and development.